416 related articles for article (PubMed ID: 37444501)
21. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.
Zhang Y; Li Q; Huang Z; Li B; Nice EC; Huang C; Wei L; Zou B
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230492
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications.
Gandhi N; Das GM
Cells; 2019 Jan; 8(2):. PubMed ID: 30691108
[TBL] [Abstract][Full Text] [Related]
23. The roles of glucose metabolic reprogramming in chemo- and radio-resistance.
Lin J; Xia L; Liang J; Han Y; Wang H; Oyang L; Tan S; Tian Y; Rao S; Chen X; Tang Y; Su M; Luo X; Wang Y; Wang H; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2019 May; 38(1):218. PubMed ID: 31122265
[TBL] [Abstract][Full Text] [Related]
24. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
Li J; Lu Z; Zhang Y; Xia L; Su Z
Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
[TBL] [Abstract][Full Text] [Related]
25. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
[TBL] [Abstract][Full Text] [Related]
26. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer.
Peng B; Zhang SY; Chan KI; Zhong ZF; Wang YT
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677797
[TBL] [Abstract][Full Text] [Related]
27. Hybrid computational modeling highlights reverse warburg effect in breast cancer-associated fibroblasts.
Aghakhani S; Silva-Saffar SE; Soliman S; Niarakis A
Comput Struct Biotechnol J; 2023; 21():4196-4206. PubMed ID: 37705596
[TBL] [Abstract][Full Text] [Related]
28. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
29. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma.
Leung RWH; Lee TKW
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358885
[TBL] [Abstract][Full Text] [Related]
30. PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities.
Xiang J; Wang K; Tang N
Genes Dis; 2023 Jan; 10(1):101-112. PubMed ID: 37013052
[TBL] [Abstract][Full Text] [Related]
31. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
Fukushi A; Kim HD; Chang YC; Kim CH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
[TBL] [Abstract][Full Text] [Related]
32. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
33. The role of metabolic reprogramming in pancreatic cancer chemoresistance.
Liu C; Li C; Liu Y
Front Pharmacol; 2022; 13():1108776. PubMed ID: 36699061
[TBL] [Abstract][Full Text] [Related]
34. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
J Exp Clin Cancer Res; ; . PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
